{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5079, "recent_count": 24, "transaction_limit": 160, "filters": {"q": "", "ticker": "MDGL", "sector": "", "industry": "", "side": "", "start": "2026-06-17", "end": "2026-08-01"}, "summary": {"total": 24, "acquisition_count": 13, "disposal_count": 11, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 1368253.4529, "disposal_value_label": "$1.4M", "net_value": -1368253.4529, "net_value_label": "$-1.4M", "flow_tone": "negative", "largest_value_label": "$372.4K", "top_sector": "Healthcare", "window_label": "17 Jun 2026 to 01 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 24, "value": "1368253.4529", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$1.4M"}], "days": [{"transaction_date": "2026-06-17", "acquisitions": 12, "disposals": 0, "total": 12, "bar_width": 100.0}, {"transaction_date": "2026-07-17", "acquisitions": 1, "disposals": 1, "total": 2, "bar_width": 16.7}, {"transaction_date": "2026-07-20", "acquisitions": 0, "disposals": 10, "total": 10, "bar_width": 83.3}], "side_mix": {"acquisitions": 13, "disposals": 11, "acquisition_share": 54.2, "disposal_share": 45.8}}, "company_flows": [{"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-20", "acquisitions": 12, "disposals": 11, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 1368253.4529, "disposed_value_label": "$1.4M", "net_value": -1368253.4529, "net_value_label": "$-1.4M", "acquisition_share": 52.2, "disposal_share": 47.8, "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}], "company_overview": [{"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-20", "filings": 24, "acquisitions": 13, "disposals": 11, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 1368253.4529, "disposed_value_label": "$1.4M", "net_value": -1368253.4529, "net_value_label": "$-1.4M", "acquisition_share": 54.2, "disposal_share": 45.8, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}], "transactions": [{"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 680.0, "share_price": 547.698, "transaction_value": 372434.64, "fetched_at": "2026-07-30T21:48:43.240900+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 545.0, "share_price": 544.714, "transaction_value": 296869.13, "fetched_at": "2026-07-30T21:48:43.245602+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 280.0, "share_price": 555.05, "transaction_value": 155414.0, "fetched_at": "2026-07-30T21:48:43.233003+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 275.0, "share_price": 545.7092, "transaction_value": 150070.03, "fetched_at": "2026-07-30T21:48:43.244031+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 269.0, "share_price": 547.0788, "transaction_value": 147164.1972, "fetched_at": "2026-07-30T21:48:43.242458+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 153.0, "share_price": 550.0138, "transaction_value": 84152.1114, "fetched_at": "2026-07-30T21:48:43.237956+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 140.0, "share_price": 542.7459, "transaction_value": 75984.426, "fetched_at": "2026-07-30T21:48:43.236345+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 110.0, "share_price": 543.7929, "transaction_value": 59817.219, "fetched_at": "2026-07-30T21:48:43.234604+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 47.0, "share_price": 548.8719, "transaction_value": 25796.9793, "fetched_at": "2026-07-30T21:48:43.239327+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1.0, "share_price": 550.72, "transaction_value": 550.72, "fetched_at": "2026-07-30T21:48:43.230996+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 50000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-30T21:48:43.248546+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Performance Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 50000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T21:48:43.247087+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "BAKER, BROS. ADVISORS LP", "executive_title": "Director", "security_type": "Non-Qualified Stock Options (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 1532.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:17:08.296413+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "BAKER, BROS. ADVISORS LP", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 908.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:17:08.292202+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "BRENNAN, DANIEL J.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 404.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:17:08.289348+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "BRENNAN, DANIEL J.", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 681.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:17:08.290768+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "DALY, JAMES M", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 766.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:17:08.282374+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "DALY, JAMES M", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 454.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:17:08.295039+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "FOUSE, JACQUALYN A", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 454.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:17:08.287972+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "FOUSE, JACQUALYN A", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 766.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:17:08.293524+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "LEVY, RICHARD S", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 454.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:17:08.284622+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "LEVY, RICHARD S", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 766.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:17:08.286437+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "TAUB, REBECCA", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 454.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:17:08.297676+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "TAUB, REBECCA", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 766.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:17:08.299067+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}